| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $16K | -69.8% | — |
| SG&A Expense | $28K | +13.9% | -80.5% |
| Operating Income | -$231K | +24.0% | +31.1% |
| Interest Expense | $36K | -20.0% | -30.3% |
| Pre-tax Income | -$314K | -113.3% | +24.9% |
| Income Tax | -$16K | -112.8% | — |
| Net Income | -$298K | -113.4% | +27.4% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $95K | +53.9% | -64.7% |
| Total Assets | $103K | +44.2% | -62.6% |
| Current Liabilities | $5.7M | -0.6% | — |
| Long-term Debt | $508 | -74.1% | — |
| Total Liabilities | $5.7M | -0.6% | -36.0% |
| Stockholders' Equity | -$2.8M | +2.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$383K | -115.7% | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $415K | +124.3% | — |
| +52.5% |